TMO financials
Thermo Fisher (TMO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- TMO revenue was $44.56B in fiscal 2025, net income $6.70B.
TMO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $44.56B | $18.24B | $7.75B | $6.70B | 17.74 |
| 2024 | $42.88B | $17.70B | $7.34B | $6.33B | 16.53 |
| 2023 | $42.86B | $17.10B | $6.86B | $6.00B | 15.45 |
| 2022 | $44.91B | $18.97B | $8.39B | $6.95B | 17.63 |
| 2021 | $39.21B | $19.64B | $10.03B | $7.72B | 19.46 |
| 2020 | $32.22B | $16.00B | $7.79B | $6.38B | 15.96 |